Table 3.
Nine Studies on Previous Survival Analysis of Esophageal Carcinosarcoma.
| Researcher | Patient inclusion time | N | Incidence rate | Treatment | 5-year survival rate | Median survival (month) |
|---|---|---|---|---|---|---|
| Wang J 8 | 1998.8-2013.8 | 24 | 0.43% | OP (24/24) | 52.40% | – |
| Zhang BH 9 | 1967.1-2008.12 | 32 | 0.35% | OP (27/32) | 57% | – |
| OP+RT (1/32) | ||||||
| OP+CT (1/32) | ||||||
| OP+RT+CT (3/32) | ||||||
| Kuo CJ 10 | 1976.1-2007.12 | 12 | 0.36% | OP (7/12) | – | 11.5 |
| CCRT( 2/12) | ||||||
| CCRT+OP( 2/12) | ||||||
| CT (1/12) | ||||||
| Yu Z 11 | 1990.1-2005.12 | 22 | 0.39% | OP (22/22) | 68.20% | – |
| Chen PC 12 | 2000.1-2009.12 | 31 | – | OP (22/31) | 33.40% | 40 |
| NCRT+OP+CT( 1/31) | ||||||
| OP+RT+CT (8/31) | ||||||
| Wang L 4 | 2000.1-2011.1 | 33 | 0.66% | OP (23/33) | 48% | 43.5 |
| OP+CT (4/33) | ||||||
| OP+RT (3/33) | ||||||
| RT+CT (1/33) | ||||||
| TCM (2/33) | ||||||
| Sano A 13 | – | 20 | – | OP (19/20) | 60% | – |
| NT (1/20) | ||||||
| Cavallin F 14 | 1980.1-2011.12 | 17 | 0.32% | OP (7/17) | 11.80% | 12 |
| NT (1/17) | ||||||
| LT (2/17) | ||||||
| ES (1/17) | ||||||
| GS (2/17) | ||||||
| OP+RT (2/17) | ||||||
| RT+OP+RT (1/17) | ||||||
| OP+CT (1/17) | ||||||
| Lyomasa 15 | 1971-1988 | 20 | 2.40% | OP (14/20) | 26.70% | – |
| OP+CT (6/20) |
Abbreviations: TCM, Traditional Chinese medicine; NT, No treatment; LT, Laser therapy; ES, Endoscopic stent; GS, Gastrostomy; OP, Operation; CT, Chemotherapy; RT, Radiotherapy.